This webpage was developed to provide the public with important information about the safety and availability of biological products.
FDA and CDC Update Information on Menactra Meningococcal Vaccine and Guillain Barre Syndrome[ARCHIVED]
- Update: Guillain-Barré Syndrome Among Recipients of Menactra® Meningococcal Conjugate Vaccine --- United States, June 2005--September 2006
FDA Public Health Notification: Donor Referral Services[ARCHIVED] FDA Public Health Notification: Update of Information about BioMedical Tissue Services[ARCHIVED]
- Brief Report: Investigation into Recalled Human Tissue for Transplantation --- United States, 2005--2006 (CDC)
- Rho(D) Immune Globulin Intravenous (Human) (WinRho SDF)
Varicella Zoster Immune Globulin (VZIG) Anticipated Short Supply and Alternate Product Availability Under an Investigational New Drug Application Expanded Access Protocol[ARCHIVED]